{
  "id": 712953,
  "title": "StandardAero CEO Russell Ford sells $1,230 in stock",
  "url": "https://urgent.news/2026/08/13/standardaero-ceo-russell-ford-sells-1-230-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-13T00:01:15.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/standardaero-ceo-russell-ford-sells-1230-in-stock-93CH-4856457"
  },
  "original_language": "en",
  "account": "StandardAero's CEO, Russell Ford, sold 41 shares of the company's common stock on August 10, 2026, for a total of $1,230. The current trading price of StandardAero stock is $27.39, which represents an 8.7% decrease over the past week. The CEO's stock sale was executed under a Rule 10b5-1 trading plan, which he established on August 18, 2025. Post-sale, Ford personally owns 14,342 shares of StandardAero and has indirectly beneficial ownership of 295,532 shares through a Family LLC. StandardAero, with a market value of $9.33 billion, is currently trading at a low PEG ratio of 0.22, indicating potential undervaluation according to InvestingPro Fair Value analysis. The company has recently reported a 4.6% increase in second-quarter revenue to $1.6 billion, coupled with a significant 24% rise in adjusted earnings to $0.40 per share and a record adjusted EBITDA margin of 14.4%. These positive financial results have led StandardAero to revise its full-year 2026 outlook for revenue, adjusted EBITDA, and adjusted EPS. Despite the stock's decline, StandardAero's financial performance and optimistic future projections continue to draw investor interest.",
  "summary": null,
  "key_points": [
    "Russell Ford sold 41 shares of StandardAero stock for $1,230 on August 10, 2026.",
    "Ford's sale executed under Rule 10b5-1 plan, reducing his direct ownership to 14,342 shares.",
    "StandardAero reports 4.6% Q2 revenue increase to $1.6 billion and 24% adjusted earnings rise."
  ],
  "editors_take": "The CEO's stock sale under a pre-established trading plan does not appear to signal a loss of confidence in the company, which has reported strong recent financial results and raised its outlook.",
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Protagonist Therapeutics CEO Dinesh Patel sells $14.9m in stock",
        "url": "https://urgent.news/2026/08/13/protagonist-therapeutics-ceo-dinesh-patel-sells-14-9m-in-stock",
        "published": "2026-08-13T00:01:05.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}